FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Axel Finckh

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Pascal Zufferey; Almut Scherer; Jean Dudler; Axel Finckh
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry.
Axel Finckh; Cem Gabay; Diego Kyburz; Burkhard Möller; Ulrich A Walker; Jean Dudler
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.
Axel Finckh; Cem Gabay; Denis Hochstrasser; Sabrina Pagano; Pascale Roux-Lombard; Sylvette Bas; Paola Chevallier-Ruggeri; Delphine S Courvoisier; Nicolas Vuilleumier
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Axel Finckh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pascal Zufferey; Almut Scherer; Jean Dudler; Axel Finckh
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry.
Joint, bone, spine : revue du rhumatisme 2013;80(2):160-4.
2012: Axel Finckh; Cem Gabay; Diego Kyburz; Burkhard Möller; Ulrich A Walker; Jean Dudler
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.
Annals of the rheumatic diseases 2012;71(10):1680-5.
2012: Axel Finckh; Cem Gabay; Denis Hochstrasser; Sabrina Pagano; Pascale Roux-Lombard; Sylvette Bas; Paola Chevallier-Ruggeri; Delphine S Courvoisier; Nicolas Vuilleumier
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?
Arthritis care & research 2012;64(6):817-25.
2012: Sophie Martin Du Pan; Cem Gabay; Almut Scherer; Axel Finckh
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients.
Annals of the rheumatic diseases 2012;71(6):997-9.
2012: Stéphane Genevay; S Viatte; Pascal Zufferey; Federico Balagué; Axel Finckh; Cem Gabay
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial.
Annals of the rheumatic diseases 2012;71(4):560-2.
2011: jean-marc waldburger; Dominique Baeten; Panayiotis Christofilopoulos; Axel Finckh; Celine Lamacchia; Gaby Palmer; Walter Reith; Christian Seemayer; Cem Gabay
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
Arthritis and rheumatism 2011;63(11):3354-63.
2011: Diego Kyburz; Beat A Michel; Axel Finckh; Cem Gabay
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.
Rheumatology (Oxford, England) 2011;50(6):1106-10.
2011: Gesa Neumann; Paola dePablo; Axel Finckh; Lori B Chibnik; Fred Wolfe; Jeffrey Duryea
Patient repositioning reproducibility of joint space width measurements on hand radiographs.
Arthritis care & research 2011;63(2):203-7.
2010: Axel Finckh; Martin R Tramèr
Osteoarthritis: Small studies overestimate the benefit of therapies for OA.
Nature reviews. Rheumatology 2010;6(11):617-8.
2010: Axel Finckh
Comparative effectiveness of rheumatoid arthritis therapies.
Current rheumatology reports 2010;12(5):348-54.
2010: Nicolas Vuilleumier; Sylvette Bas; Sabrina Pagano; Fabrizio Montecucco; Pierre-André Guerne; Axel Finckh; Christian Lovis; François Mach; Denis Hochstrasser; Pascale Roux-Lombard; Cem Gabay
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Arthritis and rheumatism 2010;62(9):2640-50.
2010: Stéphane Genevay; Sebastien Viatte; Axel Finckh; Pascal Zufferey; Federico Balagué; Cem Gabay
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2010;62(8):2339-46.
2010: Axel Finckh; Jean Dudler; Felix Wermelinger; Adrian Ciurea; Diego Kyburz; Cem Gabay; Sylvette Bas
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients.
Joint, bone, spine : revue du rhumatisme 2010;77(4):313-8.
2010: M J Nissen; Cem Gabay; A Scherer; Axel Finckh
The effect of alcohol on radiographic progression in rheumatoid arthritis.
Arthritis and rheumatism 2010;62(5):1265-72.
2010: Axel Finckh; Adrian Ciurea; Laure Brulhart; B Möller; U A Walker; D Courvoisier; Diego Kyburz; J Dudler; Cem Gabay
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
Annals of the rheumatic diseases 2010;69(2):387-93.
2009: Axel Finckh; Nick Bansback; Carlo A Marra; Aslam H Anis; Kaleb Michaud; Stanley Lubin; Marc White; Sonia Sizto; Matthew H Liang
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Annals of internal medicine 2009;151(9):612-21.
2009: Anne Lübbeke; Sylvain Duc; Guido Garavaglia; Axel Finckh; Pierre Hoffmeyer
BMI and severity of clinical and radiographic signs of hip osteoarthritis.
Obesity (Silver Spring, Md.) 2009;17(7):1414-9.
2009: Sophie Martin Du Pan; Silvia Dehler; Adrian Ciurea; Hans-Rudolf Ziswiler; Cem Gabay; Axel Finckh
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis.
Arthritis and rheumatism 2009;61(5):560-8.
2009: Axel Finckh
Early inflammatory arthritis versus rheumatoid arthritis.
Current opinion in rheumatology 2009;21(2):118-23.
2009: Gaby Palmer; Dominique Talabot-Ayer; Céline Lamacchia; Dean Toy; Christian A Seemayer; Sébastien Viatte; Axel Finckh; Dirk E Smith; Cem Gabay
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
Arthritis and rheumatism 2009;60(3):738-49.
2009: Nick Bansback; Carlo A Marra; Axel Finckh; Aslam Anis
The economics of treatment in early rheumatoid arthritis.
Best practice & research. Clinical rheumatology 2009;23(1):83-92.
2009: Cédric Bandelier; Pierre André Guerne; Stéphane Genevay; Axel Finckh; Cem Gabay
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies.
Swiss medical weekly 2009;139(3-4):41-6.
2009: Stéphane Genevay; Axel Finckh; Françoise Mezin; Enrico Tessitore; Pierre-André Guerne
Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation.
Arthritis research & therapy 2009;11(6):R169.
2009: Andrea Rubbert-Roth; Axel Finckh
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review.
Arthritis research & therapy 2009;11 Suppl 1():S1.
2009: Axel Finckh; S Dehler; C Gabay
The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
Annals of the rheumatic diseases 2009;68(1):33-9.
2008: Elisabeth Bürge; Danièle Kupper; Axel Finckh; Susan Ryerson; Armin Schnider; Béatrice Leemann
Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial.
Archives of physical medicine and rehabilitation 2008;89(10):1857-62.
2008: Stéphane Genevay; Axel Finckh; Michael Payer; Françoise Mezin; Enrico Tessitore; Cem Gabay; Pierre-André Guerne
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc.
Spine 2008;33(19):2041-6.
2008: Axel Finckh; Cem Gabay
At the horizon of innovative therapy in rheumatology: new biologic agents.
Current opinion in rheumatology 2008;20(3):269-75.
2008: Axel Finckh; Martin R Tramèr
Primer: strengths and weaknesses of meta-analysis.
Nature clinical practice. Rheumatology 2008;4(3):146-52.
2007: Sophie Martin Du Pan; Cem Gabay; Axel Finckh
A systematic review of infliximab in the treatment of early rheumatoid arthritis.
Therapeutics and clinical risk management 2007;3(5):905-11.
2007: Axel Finckh; S Dehler; Karen H Costenbader; Cem Gabay
Cigarette smoking and radiographic progression in rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(8):1066-71.
2007: Axel Finckh
[Diagnostic strategy in presence of diffuse pain].
Revue médicale suisse 2007;3(116):1562, 1565-8.
2007: Axel Finckh; Matthew H Liang
Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze.
Annals of internal medicine 2007;146(11):816-7.
2007: Stéphane Genevay; Axel Finckh; Adrian Ciurea; Anne-Marie Chamot; Diego Kyburz; Cem Gabay
Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
Arthritis and rheumatism 2007;57(4):679-85.
2007: Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvia Dehler; Sylvie Revaz; Jean Dudler; Cem Gabay
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Arthritis and rheumatism 2007;56(5):1417-23.
2007: Amélie Chollet-Janin; Axel Finckh; Jean Dudler; Pierre-André Guerne
Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.
Arthritis and rheumatism 2007;56(2):688-92.
2006: Axel Finckh; Matthew H Liang; Carmen Mugica van Herckenrode; Paola de Pablo
Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.
Arthritis and rheumatism 2006;55(6):864-72.
2006: Axel Finckh; Glinda S Cooper; Lori B Chibnik; Karen H Costenbader; Julie Watts; Helen Pankey; Patricia A Fraser; Elizabeth W Karlson
Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women.
Arthritis and rheumatism 2006;54(11):3648-54.
2006: Axel Finckh; H K Choi; F Wolfe
Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment.
Annals of the rheumatic diseases 2006;65(9):1192-7.
2006: Laure Brulhart; Adrian Ciurea; Axel Finckh; A Notter; jean-marc waldburger; Diego Kyburz; Cem Gabay
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.
Annals of the rheumatic diseases 2006;65(9):1255-7.
2006: Axel Finckh; Julia F Simard; Cem Gabay; Pierre-André Guerne
Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
Annals of the rheumatic diseases 2006;65(6):746-52.
2006: Axel Finckh; Paola de Pablo; Jeffrey N Katz; Gesa Neumann; Ying Lu; Frederick Wolfe; Jeffrey Duryea
Performance of an automated computer-based scoring method to assess joint space narrowing in rheumatoid arthritis: a longitudinal study.
Arthritis and rheumatism 2006;54(5):1444-50.
2006: Ewan C Goligher; Jeffrey Duryea; Matthew H Liang; Frederick Wolfe; Axel Finckh
Radiographic joint space width in the fingers of patients with rheumatoid arthritis of less than one year's duration.
Arthritis and rheumatism 2006;54(5):1440-3.
2006: Axel Finckh; Pascal Zufferey; Marc-André Schurch; Federico Balagué; Maurice Waldburger; Alexander K L So
Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial.
Spine 2006;31(4):377-81.
2006: Axel Finckh; Julia F Simard; Jeffrey Duryea; Matthew H Liang; Jie Huang; Synove Daneel; Adrian Forster; Cem Gabay; Pierre-André Guerne
The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study.
Arthritis and rheumatism 2006;54(1):54-9.
2005: Karen H Costenbader; Elizabeth W Karlson; Victoria Gall; Paola de Pablo; Axel Finckh; Marsha Lynch; Bonnie Bermas; Peter H Schur; Matthew H Liang
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.
Arthritis and rheumatism 2005;53(5):718-23.
2005: Axel Finckh; Isabelle Carey Berner; Bérengère Aubry-Rozier; Alexander Kai-Lik So
A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.
The Journal of rheumatology 2005;32(7):1336-40.
2005: Axel Finckh; Mark D Aronson
Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.
Annals of internal medicine 2005;142(3):212-4.
2004: Axel Finckh; Cem Gabay; Pierre-André Guerne
[Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis].
Revue médicale de la Suisse romande 2004;124(9):547-50.
2004: Axel Finckh; Daniel Van Linthoudt; Bertrand Duvoisin; Philippe Bovay; Jean-Charles Gerster
The cervical spine in calcium pyrophosphate dihydrate deposition disease. A prevalent case-control study.
The Journal of rheumatology 2004;31(3):545-9.
2004: Christine Cedraschi; Jules Desmeules; Elisabetta Rapiti; E Baumgartner; P Cohen; Axel Finckh; Anne-Françoise Allaz; TL Vischer
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management.
Annals of the rheumatic diseases 2004;63(3):290-6.
2003: Axel Finckh; Maura Iversen; Matthew H Liang
The exercise prescription in rheumatoid arthritis: primum non nocere.
Arthritis and rheumatism 2003;48(9):2393-5.
2003: Jules Desmeules; Christine Cedraschi; Elisabetta Rapiti; E Baumgartner; Axel Finckh; P Cohen; Pierre Dayer; TL Vischer
Neurophysiologic evidence for a central sensitization in patients with fibromyalgia.
Arthritis and rheumatism 2003;48(5):1420-9.
2003: Axel Finckh; Jean-Charles Gerster; Alexander Kai-Lik So
Association of spondylarthropathies with lumbar synovial cysts.
Clinical rheumatology 2003;22(1):67-9.
2002: E Baumgartner; Axel Finckh; Christine Cedraschi; TL Vischer
A six year prospective study of a cohort of patients with fibromyalgia.
Annals of the rheumatic diseases 2002;61(7):644-5.
1998: Axel Finckh; A Morabia; C Deluze; TL Vischer
Validation of questionnaire-based response criteria of treatment efficacy in the fibromyalgia syndrome.
Arthritis care and research : the official journal of the Arthritis Health Professions Association 1998;11(2):116-23.